Jamjoom Pharmaceuticals Factory Co ORD SAR 10
Jamjoom Pharmaceuticals Factory Co is a Saudi Arabian pharmaceutical manufacturing enterprise headquartered in Jeddah, Saudi Arabia. The company specializes in the development, production, and marketing of branded generic pharmaceuticals across various therapeutic categories, including gastroenterology, cardiovascular health, antibiotics, and dermatology. Its products are distributed extensively throughout Saudi Arabia and broader Middle East and North Africa markets. Principal revenue is derived through wholesale pharmaceutical sales to hospitals, clinics, and retail pharmacies. Jamjoom Pharmaceuticals Factory Co is publicly listed on the Saudi Exchange (Tadawul).
3 of the funds FundTelligence covers report a position in Jamjoom Pharmaceuticals Factory Co ORD SAR 10.
- Sector
- Health Care
- Country
- Saudi Arabia
- Funds holding it
- 3
Funds holding Jamjoom Pharmaceuticals Factory Co ORD SAR 10
- Franklin MENA Fund — Franklin Templeton · 1.63 % (full portfolio disclosed, September 2026)
- Templeton Frontier Markets Fund — Franklin Templeton · 0.58 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)